Syntrix Biosystems, Inc., is a private Washington-based biotechnology company dedicated to developing and commercializing therapeutic compounds and research platforms for the pharmaceutical, biotechnology and research markets.  Since its inception, Syntrix Biosystems has been awarded over $15 million from the National Institutes of Health in support of its development efforts. {http://www.syntrixbio.com/CompanyOverview.htm 6-6-2012}